Guy Goodwin
FMedSci
Emeritus Professor of Psychiatry
The development of better ways to treat mood disorders
My research interests are in the treatment of bipolar disorder and the application of neuroscience and technology in understanding the neurobiology of mood disorders, with a focus on developing new treatments.
I was formerly W.A.Handley Chair of Psychiatry and head of the University department of Psychiatry (1996-2011).
I am a Fellow of the American College of Neuropsychopharmacology, and have previously held the positions of President of the British Association for Psychopharmacology (2004–2005) and of the European College of Neuropsychopharmacology (ECNP, 2013-2016).
I am an Emeritus Senior Investigator on the faculty of UK National Institute for Health Research (NIHR).
I am a Thomson Reuters highly cited researcher (top 1% in field).
Recent publications
-
Regional lithium prescription rates and recurrence in bipolar disorder
Journal article
Goodwin GM., (2021), International Journal of Bipolar Disorders
-
Feasibility and efficacy of a digital CBT intervention for symptoms of Generalized Anxiety Disorder: A randomized multiple-baseline study.
Journal article
Miller CB. et al, (2021), J Behav Ther Exp Psychiatry, 70
-
Blood pressure in bipolar disorder: evidence of elevated pulse pressure and associations between mean pressure and mood instability.
Journal article
McGowan NM. et al, (2021), Int J Bipolar Disord, 9
-
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network.
Journal article
Kessing LV. et al, (2021), Eur Neuropsychopharmacol
-
The Clinical Effectiveness of Using a Predictive Algorithm to Guide Antidepressant Treatment in Primary Care (PReDicT): an open-label, randomised controlled trial
Journal article
BROWNING M. et al, (2021), Neuropsychopharmacology